Today: The Hutchison China MediTech Limited (HCM) Insider Sold £56,700 in Stock

The Hutchison China MediTech Limited (HCM) Insider Sold £56,700 in Stock

Hutchison China MediTech Limited (LON:HCM) insider Michael Howell sold 3,000 shares of Hutchison China MediTech Limited stock in a transaction that occurred on Monday, November 21st. The shares were sold at an average price of GBX 1,890 ($23.61), for a total value of £56,700 ($70,839.58).

Michael Howell also recently made the following trade(s): On Monday, October 24th, Michael Howell sold 339 shares of Hutchison China MediTech Limited stock. The shares were sold at an average price of GBX 1,825 ($22.80), for a total value of £6,186.75 ($7,729.57). On Tuesday, October 25th, Michael Howell sold 1,000 shares of Hutchison China MediTech Limited stock. The shares were sold at an average price of GBX 1,840 ($22.99), for a total value of £18,400 ($22,988.51). On Wednesday, October 26th, Michael Howell sold 3,000 shares of Hutchison China MediTech Limited stock. The shares were sold at an average price of GBX 1,850 ($23.11), for a total value of £55,500 ($69,340.33). On Friday, October 28th, Michael Howell sold 2,500 shares of Hutchison China MediTech Limited stock. The shares were sold at an average price of GBX 1,860 ($23.24), for a total value of £46,500 ($58,095.95). On Friday, October 7th, Michael Howell sold 15,000 shares of Hutchison China MediTech Limited stock. The shares were sold at an average price of GBX 1,790 ($22.36), for a total value of £268,500 ($335,457.27).

Shares of Hutchison China MediTech Limited (LON:HCM) opened at 1902.00 on Monday. The company has a 50 day moving average price of GBX 1,861.55 and a 200-day moving average price of GBX 1,854.78. The stock’s market capitalization is GBX 1.15 billion. Hutchison China MediTech Limited has a 1-year low of GBX 1,612.50 and a 1-year high of GBX 2,896.60.

Several research analysts have weighed in on the company. Beaufort Securities reiterated a “buy” rating on shares of Hutchison China MediTech Limited in a research note on Wednesday, August 3rd. Panmure Gordon restated a “buy” rating and issued a GBX 2,630 ($32.86) price target on shares of Hutchison China MediTech Limited in a research note on Monday, October 31st.

Related posts

Leave a Comment